Oligonucleotides: The Next Therapeutic Wave on the Market? (AAPS PharmSci 360)

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation, considers that status of oligonucleotides on the market.